announce

Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026

SAN DIEGO and NEW YORK, April 16, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine,…

4 hours ago

ETS, Khan Academy and TED Announce New Institute to Reimagine Higher Education for the AI Age

The new Khan TED Institute will expand access to worldclass learning and career pathways, developed in partnership with leading corporates…

2 days ago

Oceanus Group and HashKey Group Announce Strategic Partnership to Modernize Global Trade Finance via Stablecoin Settlement

SINGAPORE, April 9, 2026 /PRNewswire/ -- Oceanus Group Limited ("Oceanus"), an SGX-listed food security platform (SGX: 579), and HashKey Group…

1 week ago

Magnite to Announce First Quarter 2026 Financial Results on May 6, 2026

April 06, 2026 08:00 ET  | Source: Magnite, Inc. NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) -- Magnite (Nasdaq: MGNI),…

1 week ago

The TRATON GROUP and Applied Intuition Announce TRATON ONE OS, a Unified Software Platform for Improved Fleet Uptime Across TRATON’s Four Global Brands

MUNICH and SUNNYVALE, Calif., March 31, 2026 /PRNewswire/ -- The TRATON GROUP and Applied Intuition, Inc., the leading physical AI company, today…

2 weeks ago

L&G and Manulife Wealth & Asset Management Announce Strategic Global Partnership

LONDON and TORONTO, March 24, 2026 /PRNewswire/ -- L&G and Manulife Wealth & Asset Management (Manulife WAM) today announced a long-term…

3 weeks ago

Jet AirWerks, LLC and Stratton Aviation, LLC Announce Agreement for CFM56-5B/7B Teardowns

ARKANSAS CITY, Kan., March 17, 2026 /PRNewswire/ -- Today, Jet AirWerks, LLC an FAA Part 145 Repair Station that provides…

4 weeks ago

WHO Foundation and Novo Nordisk Announce Collaboration to Support Childhood Obesity Prevention in India

NEW DELHI, March 11, 2026 /PRNewswire/ -- The WHO Foundation and Novo Nordisk today announced a new collaboration aimed at…

1 month ago

Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026

March 08, 2026 14:00 ET  | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British Columbia and BOSTON, March 08, 2026 (GLOBE NEWSWIRE)…

1 month ago

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio

Acquisition positions Servier as a leader in pediatric low-grade glioma and expands its pipeline with programs targeting adult and pediatric…

1 month ago